Scale-Up of HIV Antiretroviral Therapy and Estimation of Averted Infections and HIV-Related Deaths — Uganda, 2004–2022
Author:
- Emilio DirlikovEDEmilio Dirlikov
- 27 January 2023
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 72 (4) , 90-94
Abstract
This report describes an increase in people with HIV infection receiving PEPFAR-supported antiretroviral therapy in Uganda.Keywords
This publication has 10 references indexed in Scilit:
- Twenty years of Prevention of Mother to Child HIV Transmission: research to implementation at a national referral hospital in UgandaAfrican Health Sciences, 2022
- Adaptations to HIV services delivery amidst the COVID-19 pandemic restrictions in Kampala, Uganda: A qualitative studyPLOS Global Public Health, 2022
- Antiretroviral Therapy for the Prevention of HIV-1 TransmissionNew England Journal of Medicine, 2016
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionCochrane Database of Systematic Reviews, 2011
- Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviourSexually Transmitted Infections, 2006
- Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesThe Lancet, 2006
- Population-Level HIV Declines and Behavioral Risk Avoidance in UgandaScience, 2004
- Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan AfricaThe Lancet, 1999
- Uganda: an AIDS control programme.1987
- SLIM DISEASE: A NEW DISEASE IN UGANDA AND ITS ASSOCIATION WITH HTLV-III INFECTIONThe Lancet, 1985